Emily Rayner

1.1k total citations
8 papers, 441 citations indexed

About

Emily Rayner is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Emily Rayner has authored 8 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Emily Rayner's work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Emily Rayner is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Emily Rayner collaborates with scholars based in Netherlands, United Kingdom and Australia. Emily Rayner's co-authors include Ian Tomlinson, David N. Church, Inge C. van Gool, Tjalling Bosse, Claire Palles, Stephen Kearsey, Daniela Moralli, Séan M. O’Cathail, Annabelle Lewis and Rachael Thomas and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature reviews. Cancer.

In The Last Decade

Emily Rayner

7 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Rayner Netherlands	6	197	176	166	144	85	8	441
Bożena Konopka Poland	13	319 1.6×	154 0.9×	113 0.7×	84 0.6×	93 1.1×	23	468
Asunción Suárez Spain	8	331 1.7×	110 0.6×	107 0.6×	156 1.1×	91 1.1×	8	575
Valeria Pensotti Italy	13	155 0.8×	111 0.6×	138 0.8×	153 1.1×	41 0.5×	30	451
H.-G. Schnürch Germany	7	203 1.0×	145 0.8×	91 0.5×	201 1.4×	44 0.5×	24	449
Shamima Yeasmin Japan	10	289 1.5×	123 0.7×	39 0.2×	115 0.8×	38 0.4×	19	442
Santiago Demajo Spain	9	281 1.4×	60 0.3×	54 0.3×	99 0.7×	107 1.3×	13	450
Hsin‐Yi Lan Taiwan	5	236 1.2×	167 0.9×	34 0.2×	219 1.5×	41 0.5×	6	463
Tatiana V. Gorodnova Russia	12	155 0.8×	107 0.6×	88 0.5×	159 1.1×	16 0.2×	23	374
Pardeep Kaurah Canada	8	182 0.9×	50 0.3×	118 0.7×	130 0.9×	24 0.3×	10	423
Angela Ziebarth United States	7	345 1.8×	125 0.7×	46 0.3×	254 1.8×	19 0.2×	11	516

Countries citing papers authored by Emily Rayner

Since Specialization

Citations

This map shows the geographic impact of Emily Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Rayner more than expected).

Fields of papers citing papers by Emily Rayner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Rayner. The network helps show where Emily Rayner may publish in the future.

Co-authorship network of co-authors of Emily Rayner

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Rayner. A scholar is included among the top collaborators of Emily Rayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Rayner. Emily Rayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Lam, A., Arnoud Boot, Hans Morreau, et al.. (2024). Assessing pathogenicity of mismatch repair variants of uncertain significance by molecular tumor analysis. Experimental and Molecular Pathology. 140. 104940–104940.

2.

Pieters, Wietske, Alexander Fish, A. Manuel Liaci, et al.. (2023). Unexpected moves: a conformational change in MutSα enables high-affinity DNA mismatch binding. Nucleic Acids Research. 51(3). 1173–1188. 9 indexed citations

3.

Rayner, Emily, Cristina Fortuño, Mark Drost, et al.. (2022). Predictive functional assay‐based classification of PMS2 variants in Lynch syndrome. Human Mutation. 43(9). 1249–1258. 5 indexed citations

4.

Rayner, Emily, Rachael Thomas, Daniela Moralli, et al.. (2019). CRISPR-Cas9 Causes Chromosomal Instability and Rearrangements in Cancer Cell Lines, Detectable by Cytogenetic Methods. The CRISPR Journal. 2(6). 406–416. 49 indexed citations

5.

Gool, Inge C. van, Emily Rayner, Elisabeth M. Osse, et al.. (2018). Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues. Clinical Cancer Research. 24(13). 3197–3203. 58 indexed citations

6.

Findlay, John M., Francesc Castro-Giner, Seiko Makino, et al.. (2016). Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy. Nature Communications. 7(1). 11111–11111. 65 indexed citations

7.

Rayner, Emily, Inge C. van Gool, Claire Palles, et al.. (2016). A panoply of errors: polymerase proofreading domain mutations in cancer. Nature reviews. Cancer. 16(2). 71–81. 254 indexed citations

8.

Goldman, Nelson C., et al.. (2007). O200 Cervical metastasis from maxillary alveolar squamous cell carcinoma. 2(1). 130–130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact